发明公开
EP1896408A1 NEW 2-AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDAEMIC DISEASES
审中-公开
用于治疗高脂血症LEIDEN NEW -2-氮杂环丁酮衍生物
- 专利标题： NEW 2-AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDAEMIC DISEASES
- 专利标题（中）： 用于治疗高脂血症LEIDEN NEW -2-氮杂环丁酮衍生物
-
申请号： EP06747952.7申请日： 2006-06-21
-
公开(公告)号： EP1896408A1公开(公告)日： 2008-03-12
- 发明人: DAHLSTRÖM, Mikael , HUNEGNAW, Fana , KARLSSON, Staffan , NORDBERG, Peter , STARKE, Ingemar
- 申请人： AstraZeneca AB
- 申请人地址： 151 85 Södertälje SE
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： 151 85 Södertälje SE
- 优先权： SE0501467 20050622
- 国际公布： WO2006137794 20061228
- 主分类号： C07D205/08
- IPC分类号： C07D205/08 ; A61K31/397 ; A61P25/28 ; A61P3/06 ; A61P9/10
摘要：
The invention relates to novel 2-azetidinone derivatives of formula (I) and to pharmaceutically acceptable salts, solvates and prodrugs thereof . The compounds are cholesterol absorption inhibitors, useful in the treatment of hyperlipidaemic conditions. The invention also relates to processes for their manufacture and to pharmaceutical compositions containing them.
信息查询
